Fenozolone
|  | |
| Clinical data | |
|---|---|
| Routes of administration | Oral | 
| ATC code | N06BA08 (WHO) | 
| Identifiers | |
| 
 | |
| CAS Number | 15302-16-6  Y | 
| PubChem (CID) | 71682 | 
| ChemSpider | 64736  Y | 
| UNII | 1NZI4LMU6G  Y | 
| KEGG | D07344  Y | 
| ChEMBL | CHEMBL2104907 | 
| ECHA InfoCard | 100.035.747 | 
| Chemical and physical data | |
| Formula | C11H12N2O2 | 
| Molar mass | 204.225 g/mol | 
| 3D model (Jmol) | Interactive image | 
| Chirality | Racemic mixture | 
| 
 | |
| 
 | |
| (verify) | |
Fenozolone (Ordinator) was developed by Laboratoires Dausse in the 1960s[1] and is a psychoactive drug and stimulant related to pemoline and 4-methylaminorex which acts as a norepinephrine-dopamine releasing agent (NDRA).[2]
See also
References
- ↑ DE Patent 1297108B - 5-phenyl-2-ethylamino-4-oxazolinone and its preparation
- ↑ Gielsdorf W (February 1982). "Determination of the psychostimulants pemoline, fenozolone and thozalinone in human urine by gas chromatography/mass spectrometry and thin layer chromatography". Journal of Clinical Chemistry and Clinical Biochemistry. 20 (2): 65–8. PMID 6121837.
This article is issued from Wikipedia - version of the 6/9/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.